Cargando…
Current Strategies for the Manufacture of Small Size Tissue Engineering Vascular Grafts
Occlusive arterial disease, including coronary heart disease (CHD) and peripheral arterial disease (PAD), is the main cause of death, with an annual mortality incidence predicted to rise to 23.3 million worldwide by 2030. Current revascularization techniques consist of angioplasty, placement of a st...
Autores principales: | Carrabba, Michele, Madeddu, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916236/ https://www.ncbi.nlm.nih.gov/pubmed/29721495 http://dx.doi.org/10.3389/fbioe.2018.00041 |
Ejemplares similares
-
Reconstruction of the Swine Pulmonary Artery Using a Graft Engineered With Syngeneic Cardiac Pericytes
por: Alvino, Valeria Vincenza, et al.
Publicado: (2021) -
Systematic Review of Tissue-Engineered Vascular Grafts
por: Durán-Rey, David, et al.
Publicado: (2021) -
Small Caliber Compliant Vascular Grafts Based on Elastin-Like Recombinamers for in situ Tissue Engineering
por: Fernández-Colino, Alicia, et al.
Publicado: (2019) -
Angiogenesis in Tissue Engineering: As Nature Intended?
por: Mastrullo, Valeria, et al.
Publicado: (2020) -
Collagen-Based Tissue Engineering Strategies for Vascular Medicine
por: Copes, Francesco, et al.
Publicado: (2019)